Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher Rovera
Targeting DDR1 and DDR2 Overcomes Matrix-Mediated Melanoma Cell Adaptation to BRAF-targeted Therapy
Related publications
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells
Clinical Cancer Research
Cancer Research
Oncology
Discordancy in BRAF Mutations Among Primary and Metastatic Melanoma Lesions: Clinical Implications for Targeted Therapy
Modern Pathology
Forensic Medicine
Pathology
Combining Checkpoint Inhibitors and BRAF-targeted Agents Against Metastatic Melanoma
OncoImmunology
Oncology
Allergy
Immunology
Beyond BRAF: Where Next for Melanoma Therapy?
British Journal of Cancer
Cancer Research
Oncology
Inhibition of YAP Function Overcomes BRAF Inhibitor Resistance in Melanoma Cancer Stem Cells
Oncotarget
Oncology
Cessation of Targeted Therapy After a Complete Response in BRAF-mutant Advanced Melanoma: A Case Series
British Journal of Cancer
Cancer Research
Oncology
BRAF,NRASandKITsequencing Analysis of Spindle Cell Melanoma
Journal of Cutaneous Pathology
Dermatology
Forensic Medicine
Pathology
Histology
Adoptive T-Cell Transfer Therapy and Oncogene-Targeted Therapy for Melanoma: The Search for Synergy
Clinical Cancer Research
Cancer Research
Oncology
SOX2-mediated Upregulation of CD24 Promotes Adaptive Resistance Towards Targeted Therapy in Melanoma
International Journal of Cancer
Cancer Research
Oncology